ALPCO Diagnostics Employee Directory
Biotechnology ResearchNew Hampshire, United States51-200 Employees
ALPCO Diagnostics is a biotechnology company with 51-200 employees, headquartered at 26 Keewaydin Drive Suite g, Salem, New Hampshire 03079, United States. The company develops and provides molecular and immunodiagnostic products for infectious and gastroenterological diseases, serving research and clinical laboratories. It has pursued strategic collaborations and corporate developments, including a 2022 merger with GeneProof and partnerships with Dynex Technologies and Gold Standard Diagnostics to expand automated testing capabilities. In December 2023, ALPCO announced FDA 510(k) clearance for its Calprotectin Immunoturbidimetric Assay. The company operates globally as a provider of specialty diagnostic solutions, with a product portfolio and information available at alpco.com.